Discovery Labs' Proprietary Aerosol Drug Delivery Technology Showcased at the International Society for Aerosols in Medicine Annual Meeting
June 22, 2011 07:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., June 22, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that scientific data relating to the Company's proprietary aerosolization technology...
Analysis of Surfaxin Data Presented in First Peer-Reviewed Manuscript Describing the Consequences of Reintubation in Preterm Neonates
June 01, 2011 07:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., June 1, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced that the Journal of Neonatal-Perinatal Medicine, a prominent, peer-reviewed journal widely...
Discovery Labs Reports First Quarter Financial Results and Provides an Update on Key Pipeline Programs
May 11, 2011 07:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 11, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today reports financial results for the first quarter ended March 31, 2011 and provides an update on key...
Discovery Labs' Aerosolized KL4 Surfactant Program Data Presented at the Pediatric Academic Societies Annual Meeting
May 04, 2011 07:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 4, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announced that new data from two scientific studies regarding the Company's aerosolized KL4 surfactant...
Discovery Labs' Aerosolized KL4 Surfactant Significantly Improves Lung Function and Survival in Established Model of Acute Lung Injury
May 03, 2011 07:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 3, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announced that new data from a study using aerosolized KL4 surfactant demonstrated a significant...
Discovery Labs Announces First Quarter 2011 Conference Call
April 28, 2011 16:05 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., April 28, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will be hosting a conference call on Wednesday, May 11, 2011, at 10:00 AM EDT. Management will provide a...
Discovery Labs' KL4 Surfactant Aerosolization Program Data to be Presented at the Pediatric Academic Societies Annual Meeting
April 20, 2011 07:30 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., April 20, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), will be presenting new data supporting its KL4 surfactant aerosolization program at the Pediatric...
Discovery Labs Reports Fourth Quarter Financial Results and Provides an Update on Key Pipeline Programs
March 22, 2011 07:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., March 22, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a biotechnology company developing surfactant therapies for respiratory disease, today reports financial...
Discovery Labs Announces Quarterly Business Update Conference Call
March 10, 2011 08:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., March 10, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will be hosting a conference call on Tuesday, March 22, 2011, at 10:00 AM EDT. Management will provide a...
Discovery Labs Announces Completion of $23.5 Million Public Offering
February 22, 2011 16:45 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Feb. 22, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that it has completed its previously announced public offering to sell an aggregate of...